Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Long-Term Investments (2012 - 2026)

Iqvia Holdings' (IQV) quarterly Long-Term Investments came in at $390.0 million in Q2 2026, up 43.38% year-over-year from $272.0 million in Q2 2025, and up 9.24% quarter-over-quarter from $357.0 million in Q1 2026.

Analysis

Iqvia Holdings (IQV) Long-Term Investments (2012 - 2026) Analysis & Trends

Iqvia Holdings has disclosed Long-Term Investments across 15 years of filings, most recently posting $390.0 million for Q2 2026.

  • In Q2 2026, Long-Term Investments rose 43.38% year-over-year to $390.0 million; the TTM figure through Jun 2026 stood at $390.0 million (up 43.38% YoY), while the FY2025 annual figure was $324.0 million, up 21.8% from the prior year.
  • Long-Term Investments came in at $390.0 million for Q2 2026 at Iqvia Holdings, up from $357.0 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $390.0 million in Q2 2026 to a low of $87.0 million in Q3 2022.
  • Average Long-Term Investments over 5 years is $194.1 million, with a median of $167.5 million recorded in 2024.
  • Year-over-year, Long-Term Investments advanced 2.27% in 2022 and jumped 98.51% in 2024.
  • Over 5 years, Long-Term Investments stood at $94.0 million in 2022, then surged by 42.55% to $134.0 million in 2023, then jumped by 98.51% to $266.0 million in 2024, then climbed by 21.8% to $324.0 million in 2025, then advanced by 20.37% to $390.0 million in 2026.
  • Per Business Quant data, the three most recent Long-Term Investments figures were $390.0 million in Q2 2026, $357.0 million in Q1 2026, and $324.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 390.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 107.23 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 206.47 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -
6 Evotec SE 574.75 Mn 148.87 Mn - 4.04 Mn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 14.78 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 390.00 Mn
Mar 31, 2026 357.00 Mn
Dec 31, 2025 324.00 Mn
Sep 30, 2025 275.00 Mn
Jun 30, 2025 272.00 Mn
Mar 31, 2025 253.00 Mn
Dec 31, 2024 266.00 Mn
Sep 30, 2024 203.00 Mn
Jun 30, 2024 181.00 Mn
Mar 31, 2024 154.00 Mn
Dec 31, 2023 134.00 Mn
Sep 30, 2023 115.00 Mn
Jun 30, 2023 107.00 Mn
Mar 31, 2023 99.00 Mn
Dec 31, 2022 94.00 Mn
Sep 30, 2022 87.00 Mn
Jun 30, 2022 92.00 Mn
Mar 31, 2022 90.00 Mn
Dec 31, 2021 88.00 Mn
Sep 30, 2021 84.00 Mn